Search

Your search keyword '"Kim, Sung Hyun"' showing total 4,018 results
Start Over Author "Kim, Sung Hyun"
4,018 results on '"Kim, Sung Hyun"'

203. Supplementary Table Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth

Author

Lee, Mee-Hyun, primary, Huang, Zunnan, primary, Kim, Dong Joon, primary, Kim, Sung-Hyun, primary, Kim, Myoung Ok, primary, Lee, Sung-Young, primary, Xie, Hua, primary, Park, Si Jun, primary, Kim, Jae Young, primary, Kundu, Joydeb Kumar, primary, Bode, Ann M., primary, Surh, Young-Joon, primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

204. Supplementary Table 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth

Author

Lee, Mee-Hyun, primary, Huang, Zunnan, primary, Kim, Dong Joon, primary, Kim, Sung-Hyun, primary, Kim, Myoung Ok, primary, Lee, Sung-Young, primary, Xie, Hua, primary, Park, Si Jun, primary, Kim, Jae Young, primary, Kundu, Joydeb Kumar, primary, Bode, Ann M., primary, Surh, Young-Joon, primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

205. Supplementary Figure 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth

Author

Lee, Mee-Hyun, primary, Huang, Zunnan, primary, Kim, Dong Joon, primary, Kim, Sung-Hyun, primary, Kim, Myoung Ok, primary, Lee, Sung-Young, primary, Xie, Hua, primary, Park, Si Jun, primary, Kim, Jae Young, primary, Kundu, Joydeb Kumar, primary, Bode, Ann M., primary, Surh, Young-Joon, primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

206. Supplementary Figure 2 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth

Author

Lee, Mee-Hyun, primary, Huang, Zunnan, primary, Kim, Dong Joon, primary, Kim, Sung-Hyun, primary, Kim, Myoung Ok, primary, Lee, Sung-Young, primary, Xie, Hua, primary, Park, Si Jun, primary, Kim, Jae Young, primary, Kundu, Joydeb Kumar, primary, Bode, Ann M., primary, Surh, Young-Joon, primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

208. Supplementary Figure Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth

Author

Lee, Mee-Hyun, primary, Huang, Zunnan, primary, Kim, Dong Joon, primary, Kim, Sung-Hyun, primary, Kim, Myoung Ok, primary, Lee, Sung-Young, primary, Xie, Hua, primary, Park, Si Jun, primary, Kim, Jae Young, primary, Kundu, Joydeb Kumar, primary, Bode, Ann M., primary, Surh, Young-Joon, primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

218. Enhancing thermoelectric performance of single-walled carbon nanotube/reduced graphene oxide composites with small organic molecules as a novel additive.

Author

Jang, Jae Gyu, Kim, Tae-hoon, Kim, Sung Hyun, and Hong, Jong-In

Subjects
SMALL molecules, GRAPHENE oxide, BISMUTH telluride, CARBON nanotubes, SEEBECK coefficient, PHONON scattering, TERNARY forms
Abstract

A small organic molecule (SOM), 2,2′-(3,3′′-dihexyl-[2,2′:5′,2′′-terthiophene]-5,5′′-diyl)bis(1-octyl-1H-phenanthro[9,10-d]imidazole) (1), was utilised as an additive to intercalate with reduced graphene oxides (rGOs–1) in a single walled-carbon nanotube (SWCNT) composite. The ternary composite formed by incorporating rGOs–1 into the SWCNTs exhibited improvements in thermoelectric (TE) and carrier transport properties through the strong interfacial π–π interaction between the rGOs–1 and SWCNTs. The SOM 1 hybridised with the SWCNT composite induced significant interfacial phonon scattering, resulting in a reduction in the thermal conductivity (κ) of the SWCNT composite with rGOs–1. As a result, the SWCNT composite incorporating rGOs–1 demonstrated a simultaneous improvement of the Seebeck coefficient by 15% and a reduction in κ by 32%, resulting in an enhancement in the TE figure of merit (6.8 ± 0.7 × 10−3 at 297 K), which was 2.3 times higher than that of the SWCNTs alone (2.9 ± 0.5 × 10−3). [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

219. Diversity of Cladosporium (Cladosporiales, Cladosporiaceae) species in marine environments and report on five new species

Author

Lee, Wonjun, Kim, Ji Seon, Seo, Chang Wan, Lee, Jun Won, Kim, Sung Hyun, Cho, Yoonhee, and Lim, Young Woon

Subjects
marine fungi, Fungi, open sea, Western Pacific, Capnodiales, Biota, taxonomy, Ascomycota, Cladosporiaceae, deep sea, Dothideomycetes, Republic of Korea, Cladosporium, intertidal zone
Abstract

Cladosporium species are cosmopolitan fungi, characterized by olivaceous or dark colonies with coronate conidiogenous loci and conidial hila with a central convex dome surrounded by a raised periclinal rim. Cladosporium species have also been discovered in marine environments. Although many studies have been performed on the application of marine originated Cladosporium species, taxonomic studies on these species are scarce. We isolated Cladosporium species from three under-studied habitats (sediment, seawater, and seaweed) in two districts including an intertidal zone in the Republic of Korea and the open sea in the Western Pacific Ocean. Based on multigenetic marker analyses (for the internal transcribed spacer, actin, and translation elongation factor 1), we identified fourteen species, of which five were found to represent new species. These five species were C. lagenariiforme sp. nov., C. maltirimosum sp. nov., C. marinum sp. nov. in the C. cladosporioides species complex, C. snafimbriatum sp. nov. in the C. herbarum species complex, and C. marinisedimentum sp. nov. in the C. sphaerospermum species complex. Morphological characteristics of the new species and aspects of differences with the already known species are described herein together with molecular data.

Published
2023

224. Supplementary Methods, Supplementary Figure Legends, Supplementary Table from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Author

Kwak, Jae-Yong, primary, Kim, Sung-Hyun, primary, Oh, Suk Joong, primary, Zang, Dae Young, primary, Kim, Hawk, primary, Kim, Jeong-A, primary, Do, Young Rok, primary, Kim, Hyeoung Joon, primary, Park, Joon Seong, primary, Choi, Chul Won, primary, Lee, Won Sik, primary, Mun, Yeung-Chul, primary, Kong, Jee Hyun, primary, Chung, Joo Seop, primary, Shin, Ho-Jin, primary, Kim, Dae-Young, primary, Park, Jinny, primary, Jung, Chul Won, primary, Bunworasate, Udomsak, primary, Comia, Narcisa Sonia, primary, Jootar, Saengsuree, primary, Reksodiputro, Arry Harryanto, primary, Caguioa, Priscilla B., primary, Lee, Sung-Eun, primary, and Kim, Dong-Wook, primary

Published
2023
Full Text
View/download PDF

225. Supplementary Figure 1C from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Author

Kwak, Jae-Yong, primary, Kim, Sung-Hyun, primary, Oh, Suk Joong, primary, Zang, Dae Young, primary, Kim, Hawk, primary, Kim, Jeong-A, primary, Do, Young Rok, primary, Kim, Hyeoung Joon, primary, Park, Joon Seong, primary, Choi, Chul Won, primary, Lee, Won Sik, primary, Mun, Yeung-Chul, primary, Kong, Jee Hyun, primary, Chung, Joo Seop, primary, Shin, Ho-Jin, primary, Kim, Dae-Young, primary, Park, Jinny, primary, Jung, Chul Won, primary, Bunworasate, Udomsak, primary, Comia, Narcisa Sonia, primary, Jootar, Saengsuree, primary, Reksodiputro, Arry Harryanto, primary, Caguioa, Priscilla B., primary, Lee, Sung-Eun, primary, and Kim, Dong-Wook, primary

Published
2023
Full Text
View/download PDF

226. Supplementary Data from Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

Author

Lee, Eung-Sirk, primary, Son, Dae-Soon, primary, Kim, Sung-Hyun, primary, Lee, Jinseon, primary, Jo, Jisuk, primary, Han, Joungho, primary, Kim, Heesue, primary, Lee, Hyun Joo, primary, Choi, Hye Young, primary, Jung, Youngja, primary, Park, Miyeon, primary, Lim, Yu Sung, primary, Kim, Kwhanmien, primary, Shim, Young Mog, primary, Kim, Byung Chul, primary, Lee, Kyusang, primary, Huh, Nam, primary, Ko, Christopher, primary, Park, Kyunghee, primary, Lee, Jae Won, primary, Choi, Yong Soo, primary, and Kim, Jhingook, primary

Published
2023
Full Text
View/download PDF

227. Supplementary Figure 3B from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Author

Kwak, Jae-Yong, primary, Kim, Sung-Hyun, primary, Oh, Suk Joong, primary, Zang, Dae Young, primary, Kim, Hawk, primary, Kim, Jeong-A, primary, Do, Young Rok, primary, Kim, Hyeoung Joon, primary, Park, Joon Seong, primary, Choi, Chul Won, primary, Lee, Won Sik, primary, Mun, Yeung-Chul, primary, Kong, Jee Hyun, primary, Chung, Joo Seop, primary, Shin, Ho-Jin, primary, Kim, Dae-Young, primary, Park, Jinny, primary, Jung, Chul Won, primary, Bunworasate, Udomsak, primary, Comia, Narcisa Sonia, primary, Jootar, Saengsuree, primary, Reksodiputro, Arry Harryanto, primary, Caguioa, Priscilla B., primary, Lee, Sung-Eun, primary, and Kim, Dong-Wook, primary

Published
2023
Full Text
View/download PDF

228. Supplementary Figure 2 from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Author

Kwak, Jae-Yong, primary, Kim, Sung-Hyun, primary, Oh, Suk Joong, primary, Zang, Dae Young, primary, Kim, Hawk, primary, Kim, Jeong-A, primary, Do, Young Rok, primary, Kim, Hyeoung Joon, primary, Park, Joon Seong, primary, Choi, Chul Won, primary, Lee, Won Sik, primary, Mun, Yeung-Chul, primary, Kong, Jee Hyun, primary, Chung, Joo Seop, primary, Shin, Ho-Jin, primary, Kim, Dae-Young, primary, Park, Jinny, primary, Jung, Chul Won, primary, Bunworasate, Udomsak, primary, Comia, Narcisa Sonia, primary, Jootar, Saengsuree, primary, Reksodiputro, Arry Harryanto, primary, Caguioa, Priscilla B., primary, Lee, Sung-Eun, primary, and Kim, Dong-Wook, primary

Published
2023
Full Text
View/download PDF

229. Data from Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

Author

Lee, Eung-Sirk, primary, Son, Dae-Soon, primary, Kim, Sung-Hyun, primary, Lee, Jinseon, primary, Jo, Jisuk, primary, Han, Joungho, primary, Kim, Heesue, primary, Lee, Hyun Joo, primary, Choi, Hye Young, primary, Jung, Youngja, primary, Park, Miyeon, primary, Lim, Yu Sung, primary, Kim, Kwhanmien, primary, Shim, Young Mog, primary, Kim, Byung Chul, primary, Lee, Kyusang, primary, Huh, Nam, primary, Ko, Christopher, primary, Park, Kyunghee, primary, Lee, Jae Won, primary, Choi, Yong Soo, primary, and Kim, Jhingook, primary

Published
2023
Full Text
View/download PDF

230. Supplemental Figure 5 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

231. Data from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

232. Supplemental Table 1 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

233. Supplemental Figure 2 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

234. Supplemental Figure 10 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

235. Supplemental Figure 4 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

236. Supplemental Figure 9 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

237. Supplemental Figure 3 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

238. Supplemental Figure 6 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

239. Supplemental Figure Legend from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

240. Supplemental Materials and Methods from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

241. Supplemental Figure 8 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

242. Supplemental Figure 7 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Author

Kim, Dong Joon, primary, Roh, Eunmiri, primary, Lee, Mee-Hyun, primary, Oi, Naomi, primary, Lim, Do Young, primary, Kim, Myoung Ok, primary, Cho, Yong-Yeon, primary, Pugliese, Angelo, primary, Shim, Jung-Hyun, primary, Chen, Hanyong, primary, Cho, Eun Jin, primary, Kim, Jong-Eun, primary, Kang, Sun Chul, primary, Paul, Souren, primary, Kang, Hee Eun, primary, Jung, Ji Won, primary, Lee, Sung-Young, primary, Kim, Sung-Hyun, primary, Reddy, Kanamata, primary, Yeom, Young Il, primary, Bode, Ann M., primary, and Dong, Zigang, primary

Published
2023
Full Text
View/download PDF

248. Efficacy and Safety of Korean Herbal Medicine for Patients with Post-Accident Syndrome, Persistent after Acute Phase: A Pragmatic Randomized Controlled Trial

Author

Hwang, Bo-Kyung, primary, Park, Kyoung Sun, additional, Ku, Seung-Hyeok, additional, Kim, Sung-Hyun, additional, Moon, Hyun-Woo, additional, Park, Mi-So, additional, Baek, Hye-Kyung, additional, Namgoong, Jin, additional, Hwangbo, Seung-Yoon, additional, Seo, Ji-Yeon, additional, Lee, Yoon Jae, additional, Lee, Jinho, additional, and Ha, In-Hyuk, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results